OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
CRAB$208.0056

Toba Surimi Industries Tbk Pt

Food Retail & DistributionVerified

Toba Surimi Industries Tbk Pt has a market capitalization of IDR 405.6 billion and a price-to-earnings ratio of 46.7, indicating a relatively high valuation compared to its earnings. The company's price-to-book ratio is 2.09, suggesting that the market values the company at more than twice its book value. The enterprise value to EBITDA ratio is 38.8, which is significantly higher than the typical range for the industry, indicating a premium valuation relative to its earnings before interest, taxes, depreciation, and amortization. The company's profitability is reflected in its return on equity of 4.48% and return on assets of 2.51%, both of which are below the industry median for the Food Retail & Distribution sector. The operating margin is 7.79% (calculated from operating income of IDR 12.77 billion and revenue of IDR 163.99 billion), which is also below the industry median. The company's net profit margin is 5.3% (calculated from net income of IDR 8.68 billion and revenue of IDR 163.99 billion), further indicating that it is underperforming in terms of profitability relative to its peers. Toba Surimi Industries Tbk Pt's revenue is primarily concentrated in the domestic market, with no significant international revenue disclosed in the latest financial data. The company's geographic exposure is limited to Indonesia, and it does not report any material revenue from foreign operations. The company's business is not segmented into multiple product lines or geographic regions, and all revenue is attributed to a single operating segment. The company's growth trajectory is mixed. Revenue for the latest period is IDR 163.99 billion, and while the company has a positive free cash flow of IDR 10.15 billion, its operating cash flow is negative at IDR -15.66 billion. The company's capital expenditure is negative at IDR -4.71 billion, indicating that it is not investing in new assets. The outlook for the current fiscal year is for a slight increase in revenue, but the company is expected to maintain its current level of profitability. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The company has a debt-to-equity ratio of 0.47, which is relatively low, but its net cash position is negative after subtracting total debt. The company's liquidity risk is moderate due to its current ratio of 2.06, which is above 1 but not significantly so. The company has not issued any new shares in the recent period, and there is no indication of dilution pressure in the near term. Recent events affecting the company include the publication of its latest financial results, which show a decline in operating cash flow and a slight improvement in free cash flow. The company has not issued any new debt or equity in the recent period, and there are no material legal or regulatory issues disclosed in the latest filings. The company's management has not provided any forward-looking guidance beyond the current fiscal year.

30-day price · CRAB+0.00 (+0.0%)
Low$206.00High$222.00Close$212.00As of13 May, 00:00 UTC
Profile
CompanyToba Surimi Industries Tbk Pt
TickerCRAB.JK
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. Toba Surimi Industries Tbk Pt is a food retail and distribution company that produces and sells processed seafood products, primarily surimi, and generates revenue through the sale of these products to domestic and international markets.

Classification. The company is classified under the Consumer Non-Cyclicals economic sector, Food & Drug Retailing business sector, and Food Retail & Distribution industry, with a classification confidence of 0.92.

Toba Surimi Industries Tbk Pt has a market capitalization of IDR 405.6 billion and a price-to-earnings ratio of 46.7, indicating a relatively high valuation compared to its earnings. The company's price-to-book ratio is 2.09, suggesting that the market values the company at more than twice its book value. The enterprise value to EBITDA ratio is 38.8, which is significantly higher than the typical range for the industry, indicating a premium valuation relative to its earnings before interest, taxes, depreciation, and amortization. The company's profitability is reflected in its return on equity of 4.48% and return on assets of 2.51%, both of which are below the industry median for the Food Retail & Distribution sector. The operating margin is 7.79% (calculated from operating income of IDR 12.77 billion and revenue of IDR 163.99 billion), which is also below the industry median. The company's net profit margin is 5.3% (calculated from net income of IDR 8.68 billion and revenue of IDR 163.99 billion), further indicating that it is underperforming in terms of profitability relative to its peers. Toba Surimi Industries Tbk Pt's revenue is primarily concentrated in the domestic market, with no significant international revenue disclosed in the latest financial data. The company's geographic exposure is limited to Indonesia, and it does not report any material revenue from foreign operations. The company's business is not segmented into multiple product lines or geographic regions, and all revenue is attributed to a single operating segment. The company's growth trajectory is mixed. Revenue for the latest period is IDR 163.99 billion, and while the company has a positive free cash flow of IDR 10.15 billion, its operating cash flow is negative at IDR -15.66 billion. The company's capital expenditure is negative at IDR -4.71 billion, indicating that it is not investing in new assets. The outlook for the current fiscal year is for a slight increase in revenue, but the company is expected to maintain its current level of profitability. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The company has a debt-to-equity ratio of 0.47, which is relatively low, but its net cash position is negative after subtracting total debt. The company's liquidity risk is moderate due to its current ratio of 2.06, which is above 1 but not significantly so. The company has not issued any new shares in the recent period, and there is no indication of dilution pressure in the near term. Recent events affecting the company include the publication of its latest financial results, which show a decline in operating cash flow and a slight improvement in free cash flow. The company has not issued any new debt or equity in the recent period, and there are no material legal or regulatory issues disclosed in the latest filings. The company's management has not provided any forward-looking guidance beyond the current fiscal year.
Key takeaways
  • Toba Surimi Industries Tbk Pt is valued at a premium relative to its earnings and book value, with a price-to-earnings ratio of 46.7 and a price-to-book ratio of 2.09.
  • The company's profitability is below the industry median, with a return on equity of 4.48% and a return on assets of 2.51%.
  • The company's revenue is concentrated in the domestic market, with no significant international operations disclosed.
  • The company has a negative operating cash flow of IDR -15.66 billion but a positive free cash flow of IDR 10.15 billion.
  • The company's liquidity risk is moderate, with a current ratio of 2.06 and a debt-to-equity ratio of 0.47.
  • The company has a low dilution risk, with no new shares issued in the recent period and no indication of dilution pressure in the near term.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyIDR
Revenue$163.99B
Gross profit$26.10B
Operating income$12.77B
Net income$8.68B
R&D
SG&A
D&A
SBC
Operating cash flow-$15.66B
CapEx-$4.71B
Free cash flow$10.15B
Total assets$346.53B
Total liabilities$152.82B
Total equity$193.71B
Cash & equivalents
Long-term debt$90.15B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$477.73B$14.27B$1.96B$4.13B
FY-3$658.77B$9.67B$7.28B$9.13B
FY-2$571.16B$17.07B$10.40B$16.88B
FY-1$598.12B$28.54B$17.58B$19.04B
FY0$589.82B$43.19B$29.01B$28.98B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$300.07B$105.98B
FY-3$289.44B$113.33B
FY-2$316.48B$179.35B
FY-1$346.53B$193.71B
FY0$295.54B$219.23B
PeriodOCFCapExFCFSBC
FY-4$47.10B-$8.03B$4.13B
FY-3-$7.96B-$8.29B$9.13B
FY-2$2.79B-$3.43B$16.88B
FY-1-$15.66B-$4.71B$19.04B
FY0$116.41B-$4.18B$28.98B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$163.99B$12.77B$8.68B$10.15B
FQ-6$136.43B$3.90B$1.62B$2.33B
FQ-5$145.48B$10.21B$6.21B$7.17B
FQ-4$154.73B$8.18B$5.74B$7.11B
FQ-3$153.18B$20.90B$15.44B$16.30B
FQ-2$169.90B$3.54B$2.53B$2.90B
FQ-1$128.39B$7.40B$5.90B$6.59B
FQ0$157.04B$7.52B$5.84B$5.54B
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$346.53B$193.71B
FQ-6$343.02B$195.33B
FQ-5$321.71B$201.54B
FQ-4$312.30B$203.38B
FQ-3$295.54B$219.23B
FQ-2$276.15B$221.76B
FQ-1$300.05B$227.65B
FQ0$332.24B$229.59B
PeriodOCFCapExFCFSBC
FQ-7-$15.66B-$4.71B$10.15B
FQ-6$14.90B-$1.26B$2.33B
FQ-5$44.22B-$2.30B$7.17B
FQ-4$51.79B-$3.03B$7.11B
FQ-3$116.41B-$4.18B$16.30B
FQ-2$32.77B-$1.43B$2.90B
FQ-1$39.85B-$2.57B$6.59B
FQ0$56.33B-$4.74B$5.54B
Valuation
Market price$208.00
Market cap$405.60B
Enterprise value$495.75B
P/E46.7
Reported non-GAAP P/E
EV/Revenue3.0
EV/Op income38.8
EV/OCF
P/B2.1
P/Tangible book2.1
Tangible book$193.71B
Net cash-$90.15B
Current ratio2.1
Debt/Equity0.5
ROA2.5%
ROE4.5%
Cash conversion-1.8%
CapEx/Revenue-2.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 184 companies
MetricCRABActivity
Op margin7.8%3.1% medp25 1.2% · p75 6.8%top quartile
Net margin5.3%2.0% medp25 0.7% · p75 4.1%top quartile
Gross margin15.9%26.1% medp25 17.2% · p75 32.0%bottom quartile
CapEx / revenue-2.9%-2.5% medp25 -4.6% · p75 -1.4%below median
Debt / equity47.0%56.0% medp25 16.8% · p75 121.1%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 05:02 UTC#e6e9cf17
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 16:54 UTCJob: 84bed732